European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across RegionsMaría G. Crespo‐Leiro, Alexandre Mebazaa, Jarosław Dróżdż et al.|European Journal of Heart Failure|2016Cited by 781
Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) studyJohan Lassus, Alexandre Mebazaa, Étienne Gayat et al.|International Journal of Cardiology|2013Cited by 237
Association Between Elevated Blood Glucose and Outcome in Acute Heart FailureAlexandre Mebazaa, James L. Januzzi, Étienne Gayat et al.|Journal of the American College of Cardiology|2013Cited by 123
Lowered B-Type Natriuretic Peptide in Response to Levosimendan or Dobutamine Treatment Is Associated With Improved Survival in Patients With Severe Acutely Decompensated Heart FailureAlain Cohen‐Solal, Alexandre Mebazaa, Damien Logeart et al.|Journal of the American College of Cardiology|2009Cited by 120
Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failureNicolas Vodovar, Alexandre Mebazaa, Marie‐France Seronde et al.|European Heart Journal|2014Cited by 109